Assessment of Blood and Follicular Fluid Immune Cell Constitution in Patients Undergoing in Vitro Fertilization
NCT01083745 · Status: UNKNOWN · Type: OBSERVATIONAL
Last updated 2010-03-18
Summary
The etiology of infertility in the majority of patients with poor response to ovarian stimulation remains unknown. This study will investigate the role of immune cells (T cells, B cells, dendritic cells and NK cells), that constitute the immune system which normally fights infection and cancer. We, the investigators, have found that specialized NK cells that help with new blood vessel formation, are found in the fluid surrounding the egg during IVF, only in patients with good response to ovarian stimulation. We now wish to expand our studies and correlate our findings to ovarian blood flow , as measured by 3D ultrasound and to the presence of other cells in the immune system.
Conditions
- Infertility, Female
Sponsors & Collaborators
-
Hillel Yaffe Medical Center
lead OTHER_GOV
Eligibility
- Min Age
- 27 Years
- Max Age
- 43 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- Israel
Study Locations
More Related Trials
-
Study of Blood Immune Cells in Cancer Patients Compared to Controls
NCT01312701 ·Status: UNKNOWN
-
The Role of Placental Myeloid Cells During Gestation, Labor and Disease
NCT01584219 ·Status: UNKNOWN
-
Hyporesponsiveness of Natural Killer Cells and a Dysfunctional Inflammatory Response in Critically Ill Patients
NCT02565589 ·Status: COMPLETED
-
In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients
NCT00001336 ·Status: COMPLETED
-
Human Blood Specimen Collection to Evaluate Immune Cell Function
NCT03422120 ·Status: COMPLETED
-
Efficacy of Low Dose, SubQ Interleukin-2 (IL-2) to Expand Endogenous Regulatory T-Cells in Liver Transplant Recipients
NCT02739412 ·Status: COMPLETED ·Phase: PHASE2
-
Natural Killer Cells Reconstitution Kinetics Post Haploidentical Transplantation
NCT02978274 ·Status: UNKNOWN
-
Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer
NCT00823524 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Single Center Study Of N-803 Stimulation On Expansion, Enrichment, Proliferation Of Natural Killer Cells Collected By Apheresis
NCT06040918 ·Status: COMPLETED ·Phase: PHASE1
-
microRNA Profile in Umbilical Cord Blood NK Cells
NCT00751569 ·Status: UNKNOWN
-
T Cells Response to SARS COV 2 Peptides
NCT04573348 ·Status: UNKNOWN
-
Immune-Related Adverse Events and Associated Biomarkers in Patients Receiving Cancer Immunotherapy
NCT06089967 ·Status: COMPLETED
-
Ph2 NK Cell Enriched DCIs w/wo RLR9 Agonist, DUK-CPG-001 From Donors Following Allogeneic SCT
NCT02452697 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
An Open Label Study of IgG Fc Glycan Composition in Human Immunity
NCT01967238 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Evaluation of Immune Signaling Networks in Healthy Human Volunteers
NCT01882582 ·Status: COMPLETED
-
Age-matched Reference Values for Circulating Natural Killer T-like Cells
NCT06450743 ·Status: COMPLETED ·Phase: NA
-
Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy
NCT01339000 ·Status: TERMINATED ·Phase: PHASE2
-
VRC 900: Evaluation of Tissue-Specific Immune Responses in Adults 18 Years of Age and Older
NCT01132859 ·Status: RECRUITING
-
Determining the Amount of Time Needed for Nelfinavir to Boost the Immune System in Adults
NCT00346619 ·Status: COMPLETED ·Phase: PHASE1
-
A Preliminary Study About Unexplained Recurrent Miscarriage and Repeated Implantation Failure Patients Treated With Low-dose Lymphocyte Immunotherapy
NCT03081325 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Lymphocytes Subpopulation in Cancer Patients
NCT02516371 ·Status: UNKNOWN ·Phase: NA
-
Identification of B Regulatory Cells by Flow Cytometry
NCT06876506 ·Status: NOT_YET_RECRUITING
-
Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19
NCT04365101 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Safety and Efficacy Study of Donor Natural Killer Cells Given After Haploidentical Hematopoietic Cell Transplantation
NCT01795378 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus
NCT02479698 ·Status: RECRUITING ·Phase: PHASE2